References
- Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998;91(1):288–294
- Steen RG, Emudianughe T, Hankins GM, et al. Brain imaging findings in pediatric patients with sickle cell disease. Radiology. 2003;228(1):216–225
- Quinn CT, Miller ST. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematol Oncol Clin North Am. 2004;18(6):1339–1354, ix
- Benedik MP, Zaletel M, Meglic NP, Podnar T. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc Interv. 2007;70(7):999–1007
- Dowling MM, Quinn CT, Rogers ZR, Journeycake JM. Stroke in sickle cell anemia: Alternative etiologies. Pediatr Neurol. 2009;41(2):124–126
- Strouse JJ, Jordan LC, Lanzkron S, Casella JF. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol. 2009;84(9):548–552
- Grace RF, Su H, Sena L, et al. Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea. Am J Hematol. 2010;85(2):135–137
- Sidani CA, Ballourah W, El Dassouki M, et al. Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: Treatment with thrombolysis. Am J Hematol. 2008;83(10):818–820
- Ware RE, Schultz WH, Yovetich N, et al. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): A phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer. 2011;57(6):1011–1017
- Casanovas-Marba N, Feijoo-Mazzo C, Guillamon-Toran L, et al. Patent foramen ovale causing severe hypoxemia due to right-to-left shunting in patients without pulmonary hypertension. Clinical suspicion clues for diagnosis and treatment. Rev Esp Cardiol. 2014;67(4):324–325
- Razdan S, Strouse JJ, Naik R, et al. Patent foramen ovale in patients with sickle cell disease and stroke: Case presentations and review of the literature. Case Rep Hematol. 2013;2013:516705. doi: 10.1155/2013/516705
- Klings ES, Machado RF, Barst RJ, et al. An official American Thoracic Society clinical practice guideline: Diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med. 2014;189(6):727–740
- Gosavi KS, Dash SK, Shah BN, et al. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: Role of hydroxyurea and partial exchange transfusion. Ann Card Anaesth. 2010;13(2):145–147